Effect of a bioactive solution on the duration of diarrhoea in adult and paediatric patients

ISRCTN ISRCTN57765025
DOI https://doi.org/10.1186/ISRCTN57765025
Secondary identifying numbers 20110101
Submission date
09/01/2015
Registration date
21/01/2015
Last edited
09/02/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Diarrhoea is a leading cause of death in children, and results in health decline and time lost at work for adults. Oral rehydration solution (ORS) is the standard of care for individuals with non-infectious diarrhoea. It reduces the dehydration caused by diarrhoea, but does not reduce the time to resolution of diarrhoea. The aim of the study is to test whether adding a novel polyphenol solution to ORS might reduce the time to resolution of the diarrhoea compared with the resolution time with ORS alone.

Who can participate?
Adults and children with diarrhoea for less than 48 hours

What does the study involve?
Participants will receive ORS plus the polyphenol solution or ORS plus water once at the start of 2 days and the resolution of diarrhoea and other intestinal symptoms will be recorded.

What are the possible benefits and risks of participating?
The benefits are the reduction of the duration of diarrhoea with no side-effects. The risk is that a patient might have an adverse event to the polyphenol solution.

Where is the study run from?
Community clinic associated with the Universidad Centroamericana de Ciencias Empresariales (Nicaragua)

When is the study starting and how long is it expected to run for?
From February 2010 to December 2010.

Who is funding the study?
LiveLeaf Inc (USA).

Who is the main contact?
Dr Thomas Lawson
tlawson@liveleaf.com

Contact information

Dr Thomas Lawson
Scientific

1160 Industrial Road
Suite 11
San Carlos
94070
United States of America

ORCiD logoORCID ID 0000-0001-5182-4681
Phone +16505177288
Email tlawson@liveleaf.com

Study information

Study designRandomised double-blind placebo-controlled crossover study
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Community
Study typeTreatment
Participant information sheet Not available in web format. Please use the contact details below to request a patient information sheet.
Scientific titleAssessment of a bioactive polyphenol solution on the duration of acute diarrhoea in adult and paediatric patients: a randomised double-blind placebo-controlled crossover study
Study objectivesConsumption of a bioactive polyphenol solution will reduce the duration of acute diarrhoea by 20%
Ethics approval(s)Institutional review board of the Universidad Centroamericana de Ciencias Empresariales (Managua, Nicaragua), 10/05/2010, 201005
Health condition(s) or problem(s) studiedAcute diarrhoea (for less than 48 hours)
Intervention1. Oral rehydration solution and bioactive solution on day 1 and then oral rehydration solution and water (placebo) on day 2
2. Oral rehydration solution and water (placebo) on day 1 and then oral rehydration solution and bioactive polyphenol solution on day 2
Intervention typeSupplement
Primary outcome measureResolution to diarrhoea, assessed as the time from ingestion of the solution to when an individual produced a stool with a Bristol Stool Scale ranking of 4 or less.
Secondary outcome measures1. Defecation urgency, ranked from 0 (none) to 10 (extreme) at the various time intervals by patients (adults) and caregivers (for children)
2. Bloating or gas, ranked from 0 (none) to 10 (extreme) at the various time intervals by patients (adults) and caregivers (for children)
3. Abdominal pain at 30, 60, 90 and 120 minutes after consumption of the solutions on day 1 and day 2; pain was ranked from 0 to 10 on the Visual Analogue Scale
Overall study start date12/02/2010
Completion date07/12/2010

Eligibility

Participant type(s)Patient
Age groupAll
SexBoth
Target number of participantsThe target total recruitment of participants was 200 patients.
Total final enrolment61
Key inclusion criteria1. 5–80 years old
2. Diarrhoea for less than 48 hours
Key exclusion criteria1. History of uncontrolled emesis
2. Grossly bloody stool
3. Fever
4. Clinical signs of a coexisting acute systemic illness (e.g., meningitis, sepsis or pneumonia)
5. Underlying chronic disease (e.g., heart disease, cystic fibrosis or diabetes)
6. Food allergies or other chronic gastrointestinal diseases
7. Use of probiotic agents in the previous 3 weeks or antibiotics or anti-diarrhoeal medications including over-the-counter and herbal substances in the previous 2 weeks
8. Generalised cachexia
9. Any signs of internal bleeding or drug abuse
10. Any condition, assessed with a standard of care, to cause unnecessary risk if participant given oral rehydration solution alone
11. Unable or unwilling to provide informed consent
Date of first enrolment14/09/2010
Date of final enrolment07/12/2010

Locations

Countries of recruitment

  • Nicaragua

Study participating centre

Community health clinic of Universidad Centroamericana de Ciencias Empresariales
Managua
-
Nicaragua

Sponsor information

LiveLeaf Inc
Industry

1160 Industrial Road
Suite 11
San Carlos
94070
United States of America

Phone +16505177288
Email tlawson@liveleaf.com
Website http://liveleaf.com
ROR logo "ROR" https://ror.org/00m48tn76

Funders

Funder type

Industry

LiveLeaf Inc

No information available

Results and Publications

Intention to publish date30/03/2015
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPublish the results from the study in a peer-reviewed journal that is indexed in PubMed
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 21/05/2015 05/03/2019 Yes No
Dataset 09/02/2023 No No

Editorial Notes

09/02/2023: Dataset added.
05/03/2019: Publication reference added.